Potential Targets for ME/CFS Clinical Trials This week showcased Bateman Horne Center’s strategic plan in action. The new research published in two separate papers in the prestigious journal, Cell Host & Microbe, provided further evidence that the microbiome and...
Signature microbiome disturbances in ME/CFS may point to biomarker and treatment trials New research reveals differences in the gut microbiomes of people with myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) compared to those of healthy controls. ME/CFS is...
Over the past 5 years, 285 of you have participated in an NIH-funded research study at Bateman Horne Center! This study was led by The Jackson Laboratory (JAX), one of the three ME/CFS Collaborative Research Centers funded by the NIH. BHC was the Clinical Core for JAX...
There are about 8 different herpes viruses that infect humans - herpes simplex virus types 1 and 2, varicella-zoster virus, cytomegalovirus, Epstein-Barr virus, human herpesvirus 6 (variants A and B), human herpesvirus 7, and Kaposi's sarcoma virus or human...
Researchers at BHC, the University of Utah and Columbia University teamed up to publish our most recent paper, Orthostatic Challenge Causes Distinctive Symptomatic, Hemodynamic and Cognitive Responses in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue...
Successful people frequently say the key to success is showing up every day and putting in the work. After that it takes determination and patience, along with good timing, a little luck, and lots of help from others to meet lofty goals. At BHC, we embrace that...
Many investigators pivoted to SARS-CoV-2 and COVID-19 science and medicine in 2020. We did too at BHC because we understood the opportunity the pandemic provided for "real-time" clinical research of post-COVID-19 sequelae and to share all we know about ME/CFS -...
In the coming weeks, BHC will start a new research study that you may be eligible to participate in! This research will assess endothelial function and upright activity in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID, which is...
The Researching COVID to Enhance Recovery (RECOVER), is an Initiative of the National Institutes of Health that aims to understand, prevent, and treat post-acute sequelae of SARS-CoV-2 (PASC), including Long COVID.
Improving Lives Today Begins with Education. Regardless of age, education, or experience, learning is the catalyst for change. You cannot influence a process, mindset, or required skill without learning what needs improvement and how to accomplish it. That is why credentialed medical providers are required to refresh and expand their knowledge base. The advent […]
When Cortene contacted BHC with an idea, and an early draft protocol designed to test CT38 as a treatment for ME/CFS, Dr. Suzanne Vernon and I agreed to help them refine the protocol and conduct the trial. The Cortene-funded trial was an FDA and IRB-approved...
Frontiers in Systems Neuroscience published the study results of Cortene Inc's investigational drug CT38 in people with ME/CFS. The trial was conducted at Bateman Horne Center and Suzanne Vernon, PhD, wrote a blog post providing context about the study. Cortene Inc....
